Articles by Laura Bush - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Laura Bush

What Comes Next

Oct 1, 2007

Today, product costs, not process science, cause the most concern.

From the Editor: Issues of Scale

Sep 1, 2007

In analyzing the industry's current challenges, let's be careful before extrapolating about what they mean.

From the Editor: After Zheng

Aug 1, 2007

The corruption of China's food and drug sectors is not limited to one man. Likewise, real reform will require the efforts of many.

From the Editor: Learning from the Diethylene Glycol Tragedies

Jul 1, 2007

Quality guidelines are only as good as their implementation.

From the Editor: On the Cusp of Profitability

Jun 1, 2007

Without charges for some large merger deals, the publicly traded US biopharmaceutical industry would have been profitable in 2006—for the first time.

From the Editor: Score One for Preparedness

May 1, 2007

Fortunately for all of us, not everyone's head is in the sand.

From the Editor: Focus on What Matters

Apr 1, 2007

Financial pressure to show short-term results also affects the pharmaceutical industry, from Big Pharma to small biotech.

CMC Strategy Forum Takes on Glycosylation

Mar 22, 2007

The biopharmaceutical industry has gained a lot of experience in monitoring glycosylation, but still has a lot to learn about the structure–function relationship.

USP Seeks Participants for Glycan Analysis Study

Mar 22, 2007

The United States Pharmacopeia (USP, Rockville, MD, www.usp.org) and the UK's National Institute for Biological Standards and Control (NIBSC, Hertfordshire, UK, www.nibsc.ac.uk) are seeking participants in a study of analytical methods used by the industry to characterize and quantify oligosaccharides.

ADVERTISEMENT

ADVERTISEMENT

Click here